日本臨床薬理学会学術総会抄録集
Online ISSN : 2436-5580
第43回日本臨床薬理学会学術総会
セッションID: 43_1-C-O02-7
会議情報

一般演題 口演
PD-L1 expression regulated by the EphA2/ephrin-A1 system in lung cancer
*家口 勝昭高柳 大輔大西 伸幸渡邊 真大熊 遼太朗鈴木 梨沙子辻 まゆみ木内 祐二角田 卓也内田 直樹小林 真一和田 聡
著者情報
会議録・要旨集 フリー

詳細
抄録

Eph tyrosine kinase receptors and their ligands, ephrin, are ubiquitously expressed in many tissues and organs and play important physiological functions as represented by neural and vascular development. In pathological settings, expression analysis using clinical samples of cancer patients shows that the Eph/ephrin system significantly contributes to tumor growth and poor prognosis in many types of cancer such as colorectal and liver cancer. A recent study has showed that EphA10 regulates the expression of PD-L1, an immune check point molecule, in some breast cancer cell lines. Accordingly, we checked if other Ephs are involved in regulation of PD-L1 expression in human cancer tissues and analyzed the expression of Ephs and ephrins in lung cancer using TCGA data set. In lung squamous cell carcinoma, EphA2 is positively correlated with PD-L1 expression, whereas EphA2 is negatively correlated with PD-L1 expression in lung adenocarcinoma. Moreover, a negative correlation was found between ephrin-A1 and PD-L1 expression in lung adenocarcinoma. We are currently investigating the molecular mechanisms in regulation of PD-L1 expression mediated by the Eph/ephrin system.

著者関連情報
© 2022 日本臨床薬理学会
前の記事 次の記事
feedback
Top